| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.200 | None | 1.000 | 15 | 0 | 2006 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2001 | 2019 | ||||||||
|
sarcoglycan beta | 0.656 | 0.346 | 9.6E-07 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2009 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2015 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2015 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2002 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.080 | None | 0.875 | 8 | 0 | 2004 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2012 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2006 | 2017 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 2009 | 2018 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 2000 | 2018 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2015 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2001 | 2019 | ||||||||
|
EPH receptor B2 | 0.374 | 0.846 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2015 | 2019 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2010 | 2019 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2015 | 2019 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2018 | 2019 | ||||||||
|
cholecystokinin | 0.453 | 0.846 | 3.3E-05 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2008 | 2019 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2002 | 2018 | ||||||||
|
chloride intracellular channel 1 | 0.601 | 0.500 | 1.9E-04 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2009 | 2018 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2001 | 2011 | |||||||||
|
stathmin 1 | 0.458 | 0.885 | 7.5E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2016 | 2017 | ||||||||
|
prominin 1 | 0.410 | 0.846 | 1.9E-22 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2010 | 2018 | ||||||||
|
TBC1 domain family member 9 | 0.399 | 0.846 | 2.8E-05 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1998 | 2019 |